Discovery & Development Drug Discovery, Advanced Medicine

Unlocking the Potential of Tricyclic Peptides – Antibody-Like Precision with Peptide Therapeutics

04/15/2025

sponsored by Biosynth

Join us for an exclusive session on CLIPS™ multicycles, a novel class of constrained tricyclic peptides with enormous potential as next-generation peptide therapeutics. Explore how tricyclic peptides replicate key features of antibodies to achieve high-affinity and high-selectivity in target binding with greatly enhanced proteolytic stability as a bonus. Discover how our unique chemistry ensures single-isomer selection early in the screening process, combined with a high-diversity screening method. We will showcase the discovery and optimization of tricyclic peptides against high-value targets, like membrane receptor proteins and monoclonal antibodies. Whether you’re in research, biotech, or pharmaceuticals, learn how high-diversity tricyclic peptide screening might support your drug development projects.

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.